Share Name Share Symbol Market Type Share ISIN Share Description
Spire Health LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.70p -0.56% 123.80p 958,060 16:35:11
Bid Price Offer Price High Price Low Price Open Price
122.90p 123.30p 127.80p 122.30p 124.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 931.70 22.70 4.20 29.5 496.5

Spire Health (SPI) Latest News

More Spire Health News
Spire Health Takeover Rumours

Spire Health (SPI) Share Charts

1 Year Spire Health Chart

1 Year Spire Health Chart

1 Month Spire Health Chart

1 Month Spire Health Chart

Intraday Spire Health Chart

Intraday Spire Health Chart

Spire Health (SPI) Discussions and Chat

Spire Health Forums and Chat

Date Time Title Posts
19/11/201811:16Spire Health1,000
15/1/201713:48Spice Holdings PLC1,547
07/10/201101:44Stanard and Very Poor-
31/1/201018:33Man, a spiritual being or an animal?192
12/8/200010:36Spirent PLC-

Add a New Thread

Spire Health (SPI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Spire Health trades in real-time

Spire Health (SPI) Top Chat Posts

Spire Health Daily Update: Spire Health is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SPI. The last closing price for Spire Health was 124.50p.
Spire Health has a 4 week average price of 103.30p and a 12 week average price of 103.30p.
The 1 year high share price is 262.80p while the 1 year low share price is currently 103.30p.
There are currently 401,081,391 shares in issue and the average daily traded volume is 1,238,277 shares. The market capitalisation of Spire Health is £496,538,762.06.
cantrememberthis2: Mediclinic last year had to write down £105m+ last year when share price was £2.25, from their initial 300p+ investment and stake of 29%. Do they write down another £120m from last year to todays share price circa 125p? Seems absurd when they COULD buy the remaining shares at substantially less than 300p, 225p in some ways. Why write off another £120m, on top of the £105m+ from previous years... i.e. £225m write down? Wow, you can by out some serious companies on the FTSE at the £250m region!!! Well,either way its been a VERY EXPENSIVE LESSON. Spire Healthcare on its knees at 125 from concerted shorting by the likes of Wallace LLP etc... who have shorted regularly from Mid Aug to as late as 8th Oct 18. The scenario created here through bad timing, NHS cost reductions and market apathy = OPPORTUNITY for others. MDC report 17OCT18. Also their CEO sits on the SPI board. Call me thick - but this is takeover territory and IF MDC are too slow to react could cost them with a predator lurking! Game on GLA, DYOR.
cantrememberthis2: Well the Brokers got their ask within DAYS from the Broker target of 130p, funny how quickly it ALWAYS seems to reach that target. Never on the broker upgrades or higher targets - shows the true power of Shorters and their crew. Sitting duck now for either Mediclinic to have another go circa 250p region (almost double todays manipulated share price) or the US HCA company that was rumoured to be sniffing around earlier this year... Then there is always the value seekers like Highclere who have stakes. I worry not for shorters on this stock as they carry the biggest RISK in my opinion should anything transpire: * Winter and NHS budgets increasing * Pressure on Waiting Lists growing * Other Private Healthcare providers folding or suffering * Predators including Private Equity looking around * Transfer of the 29.7% stake from MDC to another? * Something left of field At these very low levels regardless of the bears... I am a buyer! All IMO and DYOR
essentialinvestor: What are the negative comments?. At the tine of the bid I said Spire would be better to accept, and the sector faced challenges with cost pressures re margins, which may be underestimated. Posted that view long before the recent warning. Which of those has been incorrect, given recent results and a share price collapse since. Recently mentioned Spire now looked a sitting duck for a bid, however there's no guarantee. If you view any of that as negative, you are a very sensitive soul.
justiceforthemany: THE TIMES Meet the companies ripe for a share grab Spire Healthcare “Mediclinic217;s management will probably sigh with relief that they didn’t go ahead with a full takeover of Spire last year because the company’s shares have continued to slide. They briefly touched £1.50 a share after this week’s trading update and profit warning as NHS referrals dropped more than expected. The lower share price could tempt Mediclinic, which already owns 29.5 per cent, to return with a new offer, with Spire shareholders more willing to accept a price below last year’s offer price.”
eastbourne1982: Ebitda has changed though and as a result the bank covenants are going to become an issue soon, this is one of the main reasons for the share price fall, anything could happen here, you could get a bid however the share price could also go sub £1. A possible bid is the only positive in the short term, there are many negatives.
justiceforthemany: Spire's share price is now trading at the tangible assets value alone - if you take out all intangibles and goodwill. Crazy. Why would Mediclinic have offered 315p if Spire was truly only worth 150p? Healthcare is one of the few true defensives and will only grow with the ageing population.
jonwig: In the meantime, we downgrade our 2018 EBITDA by 16% and EPS by 37%, noting that this implies gearing of 3.7x EBITDA at the end of 2018 (covenant 4.0x). With the shares down by 20% since our upgrade, our waning confidence in our prior investment thesis prompts us to consider a stop-loss action. Our new valuation, based on EV/EBITDA and DCF metrics that reflect higher risk, leads to a 120p/share price target. We therefore set our recommendation to Sell, and believe there is potential for intangible asset write-downs and a dividend cut. Speculation regarding the potential for Mediclinic to acquire Spire helps to the limit downside, but Mediclinic’s five-year low share price, and the negative reaction to its previous bid for Spire, adds risk to relying on that get-out-of-jail-free card.
cantrememberthis2: E1982 = Very attractive share price for many non Private Investors IMO MDC Offered 315p Share Price 155p on print NHS is the NHS and skint So the news was no suprise People get ill, die etc... Its not a widow/orphans stock but man this is cheap.
che7win: Yes bounty, MDC might be barred from takeover for 6months, not sure, or unless someone else comes in with an offer.But nothing to stop others taking this over, plenty of US companies could use a weak exchange rate in their favour, never mind a weak SPI share price to offer 350p a share.Who knows, the chart has broken out from the low point though, would be nice to get to 300p from here short term.
tonysss13: Mediclinic said to weigh £1.8 billion plus takeover bid for Spire Healthcare Friday, 16 September 2016, 11:03 am Mediclinic is preparing to bid for Spire Healthcare, the FTSE 250 company that was formed from the sale of BUPA hospitals. According to excellent sources, Mediclinic is working with bankers from Morgan Stanley on the potential purchase of the remainder of Spire Healthcare that it doesn't own (remember last year Mediclinic bought 29.9pc of Spire Healthcare for 360p a share). Now, to be clear I'm not the first financial journalist to raise the prospect of a Mediclinic bid for Spire Healthcare. In late August, several British stock market reporters picked up on a note from JP Morgan, which theorised that now might be the right time for FTSE 100-listed Mediclinic to buy the remainder of Spire given the currency fluctuations post the Brexit referendum. I have pasted the relevant paragraphs from the JP Morgan note below: "In our view, the weakness in the GBP and strength of MDC’s share price vs Spire’s is an opportunity for MDC to consolidate its ownership of Spire (currently 29.9%). We estimate it could pay a 35% premium for Spire and see year one EPS increase by 3-4%, rising to 10% in year three assuming a debt-based deal. Alternatively, if MDC chose to raise equity ~£300m-500m (4-7%) in order to leave less gearing and also fund Spire’s London hospital expansion, year one accretion would drop to 2-1%. We note the authority to raise equity afforded Remgro, MDC’s largest shareholder (~44.6%), at its Aug-16th AGM." But from what I understand from excellent sources is bankers from Morgan Stanley, Mediclinic's financial advisers, are actually working on the deal suggested by the JP Morgan analyst. One source reckons Mediclinic is just a few weeks away from submitting a formal approach for Spire. I don't have much more information than that but I have been told any offer is likely to be at about a 30pc premium to the current share price. Mediclinic declined to comment. However, people familiar with the company tried to play down the tale, unsurprisingly. - See more at: hxxp://
Spire Health share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20181119 23:37:48